The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The CDK4/6 inhibitor G1T28 to protect immune cells and fibroblasts from chemotherapy and radiation-induced toxicity in vitro and to maintain efficacy of chemotherapy in SCLC Rb-deficient cells.
 
Irene Guijarro
No Relationships to Disclose
 
Warren Denning
No Relationships to Disclose
 
Renata Ferrarotto
No Relationships to Disclose
 
Alissa Poteete
No Relationships to Disclose
 
Uma Giri
No Relationships to Disclose
 
John E. Bisi
Employment - G1 Therapeutics
 
Jessica A. Sorrentino
Employment - G1 Therapeutics
 
Patrick J. Roberts
Employment - G1 Therapeutics
 
Jay Copeland Strum
Employment - G1 Therapeutics
 
Rajesh K. Malik
Employment - G1 Therapeutics
 
Emily Roarty
No Relationships to Disclose
 
John Heymach
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Exelixis; Genentech; GlaxoSmithKline; Lilly; Novartis; Synta
Research Funding - AstraZeneca; Bayer; GlaxoSmithKline